These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
723 related items for PubMed ID: 16682302
1. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. Blindt R, Vogt F, Astafieva I, Fach C, Hristov M, Krott N, Seitz B, Kapurniotu A, Kwok C, Dewor M, Bosserhoff AK, Bernhagen J, Hanrath P, Hoffmann R, Weber C. J Am Coll Cardiol; 2006 May 02; 47(9):1786-95. PubMed ID: 16682302 [Abstract] [Full Text] [Related]
3. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries. van Beusekom HM, Ertaş G, Sorop O, Serruys PW, van der Giessen WJ. Catheter Cardiovasc Interv; 2012 Feb 01; 79(2):231-42. PubMed ID: 21834062 [Abstract] [Full Text] [Related]
4. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis. Kollum M, Farb A, Schreiber R, Terfera K, Arab A, Geist A, Haberstroh J, Wnendt S, Virmani R, Hehrlein C. Catheter Cardiovasc Interv; 2005 Jan 01; 64(1):85-90. PubMed ID: 15619311 [Abstract] [Full Text] [Related]
5. Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model. Salu KJ, Bosmans JM, Huang Y, Hendriks M, Verhoeven M, Levels A, Cooper S, De Scheerder IK, Vrints CJ, Bult H. Cardiovasc Res; 2006 Feb 01; 69(2):536-44. PubMed ID: 16386237 [Abstract] [Full Text] [Related]
6. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries. Buszman P, Milewski K, Zurakowski A, Pajak J, Liszka Ł, Buszman P, Musioł E, AbuSamra M, Trznadel S, Kałuza G. Kardiol Pol; 2010 May 01; 68(5):503-9. PubMed ID: 20491008 [Abstract] [Full Text] [Related]
10. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents? Zhao FH, Chen YD, Jin ZN, Lu SZ. Med Hypotheses; 2008 Apr 01; 70(3):512-4. PubMed ID: 17764856 [Abstract] [Full Text] [Related]
11. Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries. Johnson TW, Wu YX, Herdeg C, Baumbach A, Newby AC, Karsch KR, Oberhoff M. Arterioscler Thromb Vasc Biol; 2005 Apr 01; 25(4):754-9. PubMed ID: 15681295 [Abstract] [Full Text] [Related]
12. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia. Swanson N, Hogrefe K, Javed Q, Malik N, Gershlick AH. J Invasive Cardiol; 2003 Dec 01; 15(12):688-92. PubMed ID: 14660819 [Abstract] [Full Text] [Related]
13. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries. Banai S, Gertz SD, Gavish L, Chorny M, Perez LS, Lazarovichi G, Ianculuvich M, Hoffmann M, Orlowski M, Golomb G, Levitzki A. Cardiovasc Res; 2004 Oct 01; 64(1):165-71. PubMed ID: 15364624 [Abstract] [Full Text] [Related]
14. The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents. Cho HJ, Kim TY, Cho HJ, Park KW, Zhang SY, Kim JH, Kim SH, Hahn JY, Kang HJ, Park YB, Kim HS. J Am Coll Cardiol; 2006 Jul 18; 48(2):366-74. PubMed ID: 16843188 [Abstract] [Full Text] [Related]
15. Experimental efficacy of an everolimus eluting cobalt chromium stent. Carter AJ, Brodeur A, Collingwood R, Ross S, Gibson L, Wang CA, Haller S, Coleman L, Virmani R. Catheter Cardiovasc Interv; 2006 Jul 18; 68(1):97-103. PubMed ID: 16755598 [Abstract] [Full Text] [Related]
16. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model. Collingwood R, Gibson L, Sedlik S, Virmani R, Carter AJ. Catheter Cardiovasc Interv; 2005 Jun 18; 65(2):227-32. PubMed ID: 15900559 [Abstract] [Full Text] [Related]
17. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model. Huang Y, Liu X, Wang L, Verbeken E, Li S, De Scheerder I. Int J Cardiovasc Intervent; 2003 Jun 18; 5(3):166-71. PubMed ID: 12959735 [Abstract] [Full Text] [Related]
18. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model. Tada N, Virmani R, Grant G, Bartlett L, Black A, Clavijo C, Christians U, Betts R, Savage D, Su SH, Shulze J, Kar S. Circ Cardiovasc Interv; 2010 Apr 18; 3(2):174-83. PubMed ID: 20407114 [Abstract] [Full Text] [Related]
19. Low-dose paclitaxel elution by novel bioerodible sol-gel coating on stents inhibits neointima with low toxicity in porcine coronary arteries. Shinke T, Geva S, Pendyala L, Jabara R, Li J, Chen JP, Venegoni A, Colley K, Klein R, Chronos N, Robinson K, Hou D. Int J Cardiol; 2009 Jun 12; 135(1):93-101. PubMed ID: 18692915 [Abstract] [Full Text] [Related]